Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Erbitux cetuximab: Phase III data

In the open-label, Dutch Phase III CAIRO2 trial in 381 evaluable patients with previously untreated metastatic colorectal cancer,

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE